Follow
CLIA Compliance
CLIA Compliance: regulate laboratory testing and require clinical laboratories to be certificated by their state as well as the Center for Medicare and Medicaid Services (CMS) before they can accept human samples for diagnostic testing.
-
APR 21, 2021 | 10:00 AM
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...Speaker: Sarah Wheeler, PhD , Veronica Luzzi, PhD, DABCC, FACB , Eduard Grebe, PhDSponsored By: Bio-Rad LaboratoriesDEC 11, 2020 | 7:00 AM
Date: November 16, 2020 Time: 7:00am (PST), 10:00am (EST) Join us for a webinar to learn about quality control (QC) regulations, setting the proper QC strategy/design, and troubleshoot SARs...Speaker: Sten Westgard, MS , Sharon Ehrmeyer, PhD, MT (ASCP)Sponsored By: Technopath Clinical Diagnostics USAAUG 21, 2013 | 10:00 AMC.E. CREDITS
Massively parallel sequencing technology has proven to enable the identification of driver genetic alterations in patients' tumors that may be suppressed by targeted therapies. Through retros...
APR 21, 2021 | 10:00 AM
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
Speaker:
Sarah Wheeler, PhD
, Veronica Luzzi, PhD, DABCC, FACB
, Eduard Grebe, PhD
Sponsored By: Bio-Rad Laboratories
DEC 11, 2020 | 7:00 AM
Date: November 16, 2020 Time: 7:00am (PST), 10:00am (EST) Join us for a webinar to learn about quality control (QC) regulations, setting the proper QC strategy/design, and troubleshoot SARs...
Speaker:
Sten Westgard, MS
, Sharon Ehrmeyer, PhD, MT (ASCP)
Sponsored By: Technopath Clinical Diagnostics USA
AUG 21, 2013 | 10:00 AM
C.E. CREDITS
Massively parallel sequencing technology has proven to enable the identification of driver genetic alterations in patients' tumors that may be suppressed by targeted therapies. Through retros...